Previously, higher levels of adiponectin with antifibrotic properties were demonstrated to be related to the evolution of liver fibrosis, suggesting the role of adiponectin as a non-invasive biomarker for the amelioration of liver fibrosis [43]. Here, ADIPOQ is linked to Hepatic fibrosis.